Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions

Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions

Advances in Next Generation Sequencing (NGS) technologies have enabled the accurate detection and quantification of circulating tumor-derived (ct)DNA in most gastrointestinal (GI) cancers. The prognostic and predictive utility of ctDNA in patiets with different stages of colorectal (CRC), gastro-eso...

Full description

Bibliographic Details
Main Authors: Rachel C. T. Lam, David Johnson, Gigi Lam, Michelle L. Y. Li, Joyce W. L. Wong, W. K. Jacky Lam, K. C. Allen Chan, Brigette Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
ctDNA
gastrointestinal cancer
minimal residual disease
prognostic and predictive biomarker
next generation sequencing
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.970242/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.970242/full

Similar Items